Significance of PELP1 signaling in liver cancer progression

被引：0
|
作者：
Pratap, Uday
Nassar, Khaled Mohamed
Yang, Xue
Baker, Adriana
Gopalam, Rahul
Arnold, William C.
Adeniran, Timilehin
Hernandez Fernandez, Marian Helena
Sareddy, Gangadhara R.
Viswanadhapalli, Suryavathi
Sun, Luzhe
Vadlamudi, Ratna K.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3172
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Significance and Therapeutic Potential of PELP1 in ER-Negative Breast Cancers
    Roy, S. S.
    Chakravarty, D.
    De, K.
    Tekmal, R. R.
    Sun, L. Z.
    Vadlamudi, R.
    CANCER RESEARCH, 2010, 70
  • [22] Therapeutic significance of ERα-PELP1 axis in blocking endocrine therapy resistance
    Cortez, Valerie A.
    Suzuki, Takayoshi
    Miyat, Naoki
    Sood, Anil K.
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2011, 71
  • [23] PELP1 and AIB1 cooperate to promote breast cancer progression in ER plus breast cancer models.
    Truong, Thu H.
    Hu, Hsiangyu
    Ostrander, Julie H.
    Lange, Carol A.
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 40 - 41
  • [24] Significance of PELP1/SETDB1 axis in endocrine therapy resistance.
    Liu, Zexuan
    Liu, Junhao
    Tang, Weiwei
    Pratap, Uday P.
    Altwegg, Kristin A.
    Ebrahimi, Behnam
    Li, Xiaonan
    Sareddy, Gangadhara R.
    Viswanadhapalli, Suryavathi
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2021, 81 (13)
  • [25] PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis
    Yang, Xue
    Liu, Zexuan
    Tang, Weiwei
    Pratap, Uday P.
    Collier, Alexia B.
    Altwegg, Kristin A.
    Gopalam, Rahul
    Li, Xiaonan
    Yuan, Yaxia
    Zhou, Daohong
    Lai, Zhao
    Chen, Yidong
    Sareddy, Gangadhara R.
    Valente, Philip T.
    Kost, Edward R.
    Viswanadhapalli, Suryavathi
    Vadlamudi, Ratna K.
    MOLECULAR ONCOLOGY, 2024, 18 (09) : 2136 - 2156
  • [26] Minireview: Deciphering the Cellular Functions of PELP1
    Ravindranathan, Preethi
    Lange, Carol A.
    Raj, Ganesh V.
    MOLECULAR ENDOCRINOLOGY, 2015, 29 (09) : 1222 - 1229
  • [27] Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer
    Flageng, Marianne Hauglid
    Knappskog, Stian
    Gjerde, Jennifer
    Lonning, Per Eystein
    Mellgren, Gunnar
    PLOS ONE, 2015, 10 (08):
  • [28] Therapeutic Targeting of PELP1 Prevents Ovarian Cancer Growth and Metastasis
    Chakravarty, Dimple
    Roy, Sudipa Saha
    Babu, Challa Ram
    Dandamudi, Rajasekhar
    Curiel, Tyler J.
    Vivas-Mejia, Pablo
    Lopez-Berestein, Gabriel
    Sood, Anil K.
    Vadlamudi, Ratna K.
    CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2250 - 2259
  • [29] Central Role for PELP1 in Nonandrogenic Activation of the Androgen Receptor in Prostate Cancer
    Yang, Lin
    Ravindranathan, Preethi
    Ramanan, Meera
    Kapur, Payal
    Hammes, Stephen R.
    Hsieh, Jer-Tsong
    Raj, Ganesh V.
    MOLECULAR ENDOCRINOLOGY, 2012, 26 (04) : 550 - 561
  • [30] Characterization of small molecule inhibitors of PELP1 for treating advanced breast cancer
    Altwegg, Kristin Ann
    Viswanadhapalli, Suryavathi
    Mann, Monica
    Pratap, Uday P.
    Li, Mengxing
    Liu, Junhao
    Luo, Yiliao
    Sareddy, Gangadhara R.
    Vankayalapati, Hariprasad
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2020, 80 (16)
12345